Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by HighteawithIntrepidon Aug 30, 2017 12:53am
300 Views
Post# 26635631

Cash is king

Cash is king
  • At June 30, 2017, FibroGen had $414.7 million of cash, restricted time deposits, cash equivalents, investments, and receivables
We had what 14 million. Cash is gas. No cash is sputtering 300 yards from the finish line.
When your playing in the big leagues with a minor league budget your cannon fodder. And
the last time I checked cash is PL's FUBAR not a bunch of retail investors with more time on their 
hands than money to bail out some bald headed science guy. Tell the market PLI has a product to 
fix hair loss and we're a triple over night if PL suddenly appears in the next interview with a full 
head of hair. SB I think you're living in a fantasy world if you think I will help you now, but I will say given I didn't get an FDA push on PLI today my date is probably a couple of days late. At the moment  
I see a creeping takeover with a 3.25 bid by a major as the most likely outcome. And if it is a share and cash offer from a company with dividends think of it as TST trading at .07 and getting taken out at .14 with the shorts scrambling to cover above the deal. 
Bullboard Posts